Suven Pharmaceuticals (SUVENPHAR.NSE) Q3 2025 Earnings

13AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
1.62
2.25
2.87
3.5

Details

Expected EPS
1.6218285665760002
Actual EPS
1.63202874624
Surprise EPS
0.01
Surprise Percent
+0.63%

Description

Suven Pharmaceuticals (SUVENPHAR.NSE) has reported earnings of 1.63202874624 per share for Q3 2025.

0 Comments

Share your thoughts